Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Synageva BioPharma Corp: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

17 Apr 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - SYNAGEVA BIOPHARMA CORP (GEVA-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

21 Apr 2015 Thomson Reuters Stock Report 11 $25.00

ValuEngine Industry Report for Medical-biomed/genetics(GEVA)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

21 Apr 2015 ValuEngine, Inc. 10 $49.00

GEVA: Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

21 Apr 2015 New Constructs, LLC 9 $25.00

"The Economy Matters" Report for GEVA: the economy's impact on GEVA's price and risk, featuring the powerful Economic Climate Rating and the new MacroRisk "Stoplight" and Risk Correspondence Score

"The Economy Matters"(r) Reports feature the powerful Economic Climate Rating and MacroRisk "Stoplight" to help you in your a...

20 Apr 2015 MacroRisk Analytics/EconomicInvestor 8 $25.00

ValuEngine Rating and Forecast Report for GEVA

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

20 Apr 2015 ValuEngine, Inc. 10 $25.00

US MARKET ANALYSIS AND FORECAST. 70 PAGE REPORT PUBLISH QUARTERLY. IN EACH REPORT YOU WILL FIND 12-MONTHS FORECASTS ANALYSIS TARGET PRICE VALUATION RATINGS AND CREUDE OIL DEPENDENCE FOR 7396 US STOCKS.

20 Apr 2015 Pechala's Reports 85 $1,000.00

Value Graph: SYNAGEVA BIOPHAR -- GEVA

17 Apr 2015 Ford Investor Services, Inc. 1 $12.00

TheStreet.com Ratings Stock Report For: SYNAGEVA BIOPHARMA CORP (GEVA)

12 Apr 2015 TheStreet.com Ratings 5 $10.00

Synageva BioPharma Corp. (GEVA) - Financial Analysis Review

Synageva BioPharma Corp. (GEVA) - Financial Analysis Review Summary Synageva BioPharma Corp. (Synageva) is a biopharmac...

06 Apr 2015 GlobalData 44 $125.00